...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Halted

Yes, which is what I posted.  Totally different unrelated companies/listings.  I just found it peculiar that even on the ZENI.P listing they erroneously direct you to www.zenithepigenetics.com as the companies (Zenith Capital Corporation's) website.

Share
New Message
Please login to post a reply